Synthesis, structure, and properties of rigid‐rod polymers with special emphasis on poly(p‐phenylene benzobisoxazole) (PBO) and poly(p‐phenylene benzobisthiazole) (PBZT) have been reviewed. Recent studies on chemical modifications and molecular simulations have also been given. After nearly 20 years of research and development, PBO fiber was commercialized in the late 1990s. However, due to processing difficulties, the concept of the so called molecular composites has not been successful. Development of the high compressive strength M5 and dihydroxy‐PBI fibers clearly suggest that there is potential for further developing properties of this class of materials. Opto‐electronic properties have also been reviewed.Synthesis of PBZT.magnified imageSynthesis of PBZT.
Monomethyl-pendant poly(p-phenylene benzobisimidazole) (MePBI) has been spun into fiber
and compared with an analogous methyl-pendant poly(p-phenylene benzobisthiazole) (MePBZT). From
FTIR and WAXD, the former system has been found to exhibit intermolecular hydrogen bonding, while
the latter possesses only weak van der Waals interactions. The thermomechanical properties of both
systems, as examined by TGA, TMA, and DMS, are presented and discussed. A crystal structure of MePBI
is proposed, which suggests intermolecular hydrogen bonding only between pairs of chains within the
MePBI crystal. As compared to MePBZT and other rigid-rod polymers where the intermolecular hydrogen
bond is not present, MePBI has higher compressive strength. The relatively high compressive strength
of MePBI is attributed to increased intermolecular association, as opposed to differences in morphology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.